Deutsche Bank’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-407,806
| Closed | -$129K | – | 5126 |
|
|
2018
Q1 | $129K | Buy |
407,806
+407,780
| +1,568,385% | +$129K | ﹤0.01% | 4236 |
|
|
2017
Q4 | $0 | Sell |
26
-114,000
| -100% | – | ﹤0.01% | 4654 |
|
|
2017
Q3 | $164K | Sell |
114,026
-1,762
| -2% | -$2.53K | ﹤0.01% | 3816 |
|
|
2017
Q2 | $186K | Sell |
115,788
-2,610
| -2% | -$4.19K | ﹤0.01% | 3814 |
|
|
2017
Q1 | $401K | Buy |
118,398
+115,525
| +4,021% | +$391K | ﹤0.01% | 3112 |
|
|
2016
Q4 | $14K | Buy |
2,873
+2,006
| +231% | +$9.78K | ﹤0.01% | 4274 |
|
|
2016
Q3 | $20K | Sell |
867
-660
| -43% | -$15.2K | ﹤0.01% | 4184 |
|
|
2016
Q2 | $37K | Buy |
1,527
+515
| +51% | +$12.5K | ﹤0.01% | 4264 |
|
|
2016
Q1 | $29K | Sell |
1,012
-489
| -33% | -$14K | ﹤0.01% | 4239 |
|
|
2015
Q4 | $55K | Sell |
1,501
-12,673
| -89% | -$464K | ﹤0.01% | 4080 |
|
|
2015
Q3 | $689K | Buy |
14,174
+6,444
| +83% | +$313K | ﹤0.01% | 3121 |
|
|
2015
Q2 | $532K | Sell |
7,730
-14,567
| -65% | -$1M | ﹤0.01% | 3282 |
|
|
2015
Q1 | $796K | Sell |
22,297
-3,113
| -12% | -$111K | ﹤0.01% | 2959 |
|
|
2014
Q4 | $321K | Buy |
25,410
+3,125
| +14% | +$39.5K | ﹤0.01% | 3844 |
|
|
2014
Q3 | $342K | Buy |
22,285
+3,125
| +16% | +$48K | ﹤0.01% | 3615 |
|
|
2014
Q2 | $519K | Sell |
19,160
-546
| -3% | -$14.8K | ﹤0.01% | 3346 |
|
|
2014
Q1 | $528K | Sell |
19,706
-3,701
| -16% | -$99.2K | ﹤0.01% | 3295 |
|
|
2013
Q4 | $574K | Sell |
23,407
-5,017
| -18% | -$123K | ﹤0.01% | 3007 |
|
|
2013
Q3 | $913K | Buy |
28,424
+5,398
| +23% | +$173K | ﹤0.01% | 3045 |
|
|
2013
Q2 | $681K | Buy |
+23,026
| New | +$681K | ﹤0.01% | 2964 |
|